Market Place
Sourcing Support
Bio-Path Holdings Provides Clinical Update and Expansion Plans
08 Jul 2024 //
GLOBENEWSWIRE
Bio-Path Holdings Reports First Quarter 2024 Financial Results
15 May 2024 //
GLOBENEWSWIRE
Bio-Path Holdings Reports Full Year 2023 Financial Results
08 Mar 2024 //
GLOBENEWSWIRE
Bio-Path to Announce Fourth Quarter and Full Year 2023 Financial Results
01 Mar 2024 //
GLOBENEWSWIRE
Bio-Path Holdings Reports Full Year 2022 Financial Results
31 Mar 2023 //
GLOBENEWSWIRE
Bio-Path to Announce Fourth Quarter and Full Year 2022 Financial Results
24 Mar 2023 //
GLOBENEWSWIRE
Bio-Path Holdings Announces First Patient Dosed in Ph 1/1b Trial of BP1001
07 Dec 2022 //
GLOBENEWSWIRE
Bio-Path Holdings, Inc. Announces $2.0 Million Registered Direct Offering
07 Nov 2022 //
GLOBENEWSWIRE
Bio-Path Announces First Patient Dosed in Phase 1/1b Study of BP1002
24 Oct 2022 //
GLOBENEWSWIRE
Bio-Path Holdings to Present at H.C. Wainwright 24th AnnualGIC
06 Sep 2022 //
GLOBENEWSWIRE
Bio-Path Holdings Reports Second Quarter 2022 Financial Results
16 Aug 2022 //
GLOBENEWSWIRE
Bio-Path Holdings to Announce Second Quarter 2022 Financial Results
09 Aug 2022 //
GLOBENEWSWIRE
Bio-Path Holdings Reports First Quarter 2022 Financial Results
17 May 2022 //
GLOBENEWSWIRE
Bio-Path Holdings to Announce First Quarter 2022 Financial Results
10 May 2022 //
GLOBENEWSWIRE
Bio-Path Holdings Appoints Aline Sherwood to Board of Directors
06 Apr 2022 //
GLOBENEWSWIRE
Bio-Path Holdings Reports Full Year 2021 Financial Results
11 Mar 2022 //
GLOBENEWSWIRE
Bio-Path Holdings to Present at the 2022 AACR
08 Mar 2022 //
GLOBENEWSWIRE
Bio-Path Holdings to Present Clinical Data at ASH 2021
04 Nov 2021 //
GLOBENEWSWIRE
Bio-Path Holdings Announces Clearance INDA for Ph 1/1bTrial of Prexigebersen-A
27 Oct 2021 //
BIOPATHHOLDINGS
Bio-Path Holdings Announces Clearance of IND Application for BP1002 in r/r AML
24 Aug 2021 //
GLOBENEWSWIRE
Bio-Path Holdings Reports Second Quarter 2021 Financial Results
13 Aug 2021 //
GLOBENEWS WIRE
Bio-Path Holdings to Announce Second Quarter 2021 Financial Results
06 Aug 2021 //
GLOBENEWSWIRE
Bio-Path Granted Key Mechanism of Action U.S. Patent for BP1003
22 Jun 2021 //
GLOBENEWSWIRE
Bio-Path Announces Publication in Biomedicines
22 Apr 2021 //
GLOBENEWSWIRE
Bio-Path Holdings Presents BP1002 Data at 2021 American Association
13 Apr 2021 //
GLOBNEWSWIRE
Bio-Path Announces First Patient Dosed in Phase 1 Clinical Trial of BP1002
20 Nov 2020 //
BIOSPACE
Bio-Path Holdings Announces First Patient Dosed in Amended St2 of the Ph2 Trial
13 Aug 2020 //
GLOBENEWSWIRE
Bio-Path Holdings Presents at 2020 American Society of Clinical Oncology
29 May 2020 //
GLOBENEWSWIRE
Bio-Path Holdings Presents at 2020 American Association for Cancer Research
27 Apr 2020 //
GLOBENEWSWIRE
Bio-Path Holdings to Present at 2020 American Association for Cancer Research
13 Apr 2020 //
GLOBENEWSWIRE
